Transaction DateRecipientSharesTypePriceValue
23rd October 2020Timothy A Springer994,488Open or private purchase$2.71$2,699,736.57
22nd October 2020Timothy A Springer1,770,204Open or private purchase$2.63$4,656,698.64
21st October 2020Timothy A Springer880,000Open or private purchase$2.50$2,199,472.00
20th October 2020Timothy A Springer910,000Open or private purchase$2.21$2,013,193.00
20th October 2020Holdings A/S Novo737,071Conversion of derivative$0.00
20th October 2020Holdings A/S Novo2,442,080Conversion of derivative$0.00
20th October 2020Holdings A/S Novo150,000Open or private purchase$18.00$2,700,000.00
20th October 2020Holdings A/S Novo200,000Open or private purchase$15.00$3,000,000.00
20th October 2020Holdings A/S Novo2,414,563Conversion of derivative$0.00
19th October 2020Timothy A Springer759,500Open or private purchase$2.36$1,795,002.30
Morphic Holding
Morphic Holding logo

Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 7/10.

Morphic Holding, Inc. engages in the research and development of oral small-molecule integrin therapeutics. It operates a Morphic integrin technology platform, MInT platform, to create a broad pipeline.

Ticker: MORF
Sector: Healthcare
Industry: Biotechnology
SEC Central Index Key (CIK): 1679363
Employees: 37
Exchange: NASDAQ
Auditor Opinion:

Disclosure Language changes
Red Flags